Doctors Who Prescribe Entrectinib (Rozlytrek) in Michigan
Also known as: Rozlytrek
Find doctors, physicians, and healthcare providers who prescribe Entrectinib in Michigan. This page lists the top prescribers of Entrectinib based on Medicare Part D data, including the number of claims, patients served, and total drug costs.
What is Entrectinib?
ROZLYTREK is a kinase inhibitor indicated for the treatment of: adults with ROS1- positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. ( 1.
Total Claims in Michigan
23
9.9% of all Entrectinib prescriptions nationwide
Total Beneficiaries in Michigan
0
Suppressed — CMS omits counts below 11 for privacy
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services. Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.